| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
SAN JOSE, Calif.—With an eye to helping global scientists and clinicians anticipate and prepare for emerging infectious diseases, IBM has released Spatiotemporal Epidemiological Modeler (STEM), an open-source tool to predict disease transmission across countries, through Eclipse's Open Healthcare Framework Project. The tool was developed by scientists at IBM's Almaden, Haifa, and Watson labs.
 
"STEM will allow public health officials to model the spread of a disease much like modeling a storm or hurricane—it allows us to produce a public health 'weather map' for the spread of a particular disease," says Joseph Jasinski, program director of IBM Healthcare and Life Sciences. "Until now, it has been difficult to simulate health crisis scenarios on a global scale. STEM gives us the power to do that."
 
Running on any operating system, STEM generates graphical representations of disease spread based on parameters such as demographics, geography, macro-economic data, and human and disease vector travel patterns. Being open-source, the platform can be customized by end users to fit their specific requirements, and is already being used in the Global Pandemic Initiative.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue